Literature DB >> 9692057

Cytotoxic effect of pingyangmycin on cultured KB cells.

K W Tai1, Y C Chang, L S Chou, M Y Chou.   

Abstract

The antitumour antibiotic pingyangmycin (PYM; bleomycin A5) was isolated from many components of bleomycin (BLM) produced by Streptomyces pingyangensisn. PYM has a similar chemical structure to that of BLM but the terminal amine moiety is different. Therefore, it would be of significance to demonstrate the antitumour effect and action mechanism of PYM on cultivated tumour cells. In this study, we used the cell growth curve, plating efficiency, and DNA synthesis inhibition assay to demonstrate the cytotoxicity of PYM on cultured KB cells. In the meantime, the morphological variations of drug-treated cells were also observed. In addition, we used the DNA precipitation assay, a simple and rapid assay, for detecting DNA damage caused by PYM on cultured KB cells for potential genotoxicity. Our results indicate that the effect of PYM significantly inhibits the cell growth, colonyforming ability, and DNA synthesis of KB cells in a dose-dependent manner. Furthermore, when treated with 5 micrograms/ml of PYM for 24 h on cultured KB cells, DNA strand breaks can be induced (P < 0.05). Therefore, it is considered that the action mechanism of PYM is due to its ability to inhibit the synthesis of DNA and split the DNA chains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692057     DOI: 10.1016/s1368-8375(97)00089-4

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

Review 1.  Classification and treatment of orbital venous malformations: an updated review.

Authors:  Tianyuan Li; Renbing Jia; Xianqun Fan
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

2.  Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation.

Authors:  Chuan-Kun Shan; Yi-Bo Du; Xiao-Tian Zhai; Yue-Xuan Wang; Yi Li; Jian-Hua Gong; Zhi-Juan Ge; Xiu-Jun Liu; Yong-Su Zhen
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-03       Impact factor: 3.333

3.  Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results.

Authors:  J Spence; T Krings; K G terBrugge; L B da Costa; R Agid
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

4.  Systemic immunoresponses in mice after repeated exposure of lungs to spores of Streptomyces californicus.

Authors:  J Jussila; J Pelkonen; V-M Kosma; J Mäki-Paakkanen; H Komulainen; M-R Hirvonen
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

5.  Clinical evaluation and animal experimental study of different mass concentrations of pingyangmycin in the local injection treatment of lip venous malformation.

Authors:  Weili Yuan; Xukai Wang; Lei Xue; Fang Zhang
Journal:  Ann Transl Med       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.